Xu Z X, Rooney S A
Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06510.
Biochim Biophys Acta. 1989 Oct 17;1005(3):209-16. doi: 10.1016/0005-2760(89)90039-8.
There is a developmental increase in fatty acid biosynthesis and surfactant production in late-gestation fetal lung and both are accelerated by glucocorticoids. We have examined the distribution of the newly synthesized fatty acids to determine whether they are preferentially incorporated into surfactant. Explants of 18 day fetal rat lung were cultured with and without dexamethasone for 48 h and then with [3H]acetate for 4 h after which labeled fatty acids were measured. Incorporation of radioactivity from acetate was considered a measure of newly synthesized fatty acids. Phospholipids contained 86% of the newly synthesized fatty acids of which approx. 80% were in phosphatidylcholine. Phosphatidylcholine and disaturated phosphatidylcholine contained a much greater percentage of the labeled fatty acids than of the phospholipid mass determined by phosphorus assay while phosphatidylethanolamine, phosphatidylserine and sphingomyelin contained less. Dexamethasone increased the rate of acetate incorporation into total lipid fatty acids but it had little effect on fatty acid distribution, except that it increased the percentages in phosphatidylglycerol and disaturated phosphatidylcholine. The hormone also increased the mass of these two phospholipids to a greater extent than that of the total. These data suggested that the newly synthesized fatty acids are preferentially incorporated into surfactant phospholipids and that this process is accelerated by dexamethasone. However, since phosphatidylcholine and phosphatidylglycerol are not exclusive to surfactant, we compared isolated lamellar bodies with a residual fraction not enriched in surfactant. The rate of acetate incorporation into fatty acids in lamellar body phosphatidylcholine as well as its specific activity (radioactivity per unit phosphorus) were both increased by dexamethasone. Specific activity, however, was no greater in the lamellar bodies than in the residual fraction in both control and dexamethasone-treated cultures. Therefore, there is no preferential incorporation of newly synthesized fatty acids into phospholipids in surfactant as opposed to those in other components of the lung.
妊娠晚期胎儿肺中脂肪酸生物合成和表面活性剂产生呈发育性增加,且二者均被糖皮质激素加速。我们研究了新合成脂肪酸的分布,以确定它们是否优先掺入表面活性剂中。将18日龄胎鼠肺外植体在有和没有地塞米松的情况下培养48小时,然后用[3H]乙酸盐培养4小时,之后测量标记的脂肪酸。乙酸盐放射性的掺入被视为新合成脂肪酸的一种度量。磷脂含有新合成脂肪酸的86%,其中约80%存在于磷脂酰胆碱中。磷脂酰胆碱和二饱和磷脂酰胆碱所含标记脂肪酸的百分比远高于通过磷测定法确定的磷脂总量,而磷脂酰乙醇胺、磷脂酰丝氨酸和鞘磷脂所含较少。地塞米松增加了乙酸盐掺入总脂质脂肪酸的速率,但对脂肪酸分布影响不大,只是增加了磷脂酰甘油和二饱和磷脂酰胆碱中的百分比。该激素还使这两种磷脂的质量增加幅度大于总量。这些数据表明新合成的脂肪酸优先掺入表面活性剂磷脂中,且该过程被地塞米松加速。然而,由于磷脂酰胆碱和磷脂酰甘油并非表面活性剂所特有,我们将分离的板层小体与未富集表面活性剂的残余部分进行了比较。地塞米松增加了板层体磷脂酰胆碱中脂肪酸掺入乙酸盐的速率及其比活性(每单位磷的放射性)。然而,在对照和地塞米松处理的培养物中,板层小体中的比活性并不比残余部分更高。因此,与肺的其他成分中的磷脂相比,新合成的脂肪酸并没有优先掺入表面活性剂中的磷脂。